Standout Papers

Efficacy and Safety of Alirocumab in Redu... 2001 2026 2009 2017 1.6k
  1. Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events (2015)
    Jennifer G. Robinson, Michel Farnier et al. New England Journal of Medicine
  2. Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial (2001)
    Umesh Chaudhari, L T Dooley et al. The Lancet
  3. Efficacy and safety of alirocumab in high cardiovascular risk patients with inadequately controlled hypercholesterolaemia on maximally tolerated doses of statins: the ODYSSEY COMBO II randomized controlled trial (2015)
    Christopher P. Cannon, Bertrand Cariou et al. European Heart Journal
  4. Efficacy and safety of the proprotein convertase subtilisin/kexin type 9 inhibitor alirocumab among high cardiovascular risk patients on maximally tolerated statin therapy: The ODYSSEY COMBO I study (2015)
    Dean J. Kereiakes, Jennifer G. Robinson et al. American Heart Journal

Immediate Impact

4 by Nobel laureates 21 from Science/Nature 70 standout
Sub-graph 1 of 18

Citing Papers

Durable and efficient gene silencing in vivo by hit-and-run epigenome editing
2024 StandoutNature
Global Effect of Modifiable Risk Factors on Cardiovascular Disease and Mortality
2023 Standout
1 intermediate paper

Works of Umesh Chaudhari being referenced

Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events
2015 Standout
Efficacy and safety of the proprotein convertase subtilisin/kexin type 9 inhibitor alirocumab among high cardiovascular risk patients on maximally tolerated statin therapy: The ODYSSEY COMBO I study
2015 Standout
and 1 more

Author Peers

Author Last Decade Papers Cites
Umesh Chaudhari 1265 2379 458 1149 46 4.2k
Deborah Stocken 823 3075 988 192 116 9.1k
Lixia Jiao 295 1402 241 165 26 3.2k
John Q. Su 534 732 690 86 56 4.0k
Philippe Lesnik 1482 2519 1071 204 89 5.7k
Michael A. Bolognese 339 2104 3694 638 69 8.4k
Jean Bergeron 524 3178 838 1039 80 5.9k
Thomas H. Cartwright 446 1469 3317 260 81 11.0k
Eva Tuomilehto‐Wolf 500 1798 453 263 67 3.5k
Gershon Y. Locker 325 1031 2202 189 75 9.2k
Brian A. Ference 496 3426 770 856 66 6.0k

All Works

Loading papers...

Rankless by CCL
2026